Pneumonia Clinical Trial
Official title:
A Pedagogical Research on Use of an Online Learning Platform by Final Year Medical on Under Five Pneumonia
Verified date | July 2020 |
Source | University of Edinburgh |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Despite the availability of standard pneumonia management guidelines and multiple global
efforts, pneumonia continues to be the leading killer of children under five, accounting to
around 17% of the total under five deaths globally. In Pakistan, pneumonia contributes to 16%
of under five mortality in the country having a well-defined yet poorly functional healthcare
system.
Although, there are standard set of guidelines for management of pneumonia patients however,
the management practices of this illness are variable across the country. This could be
attributed to non-availability of work ready graduates which in turn is due to variations of
teaching methods across various institutions. Although the medical students across these
institutions do get exposed to clinical cases in the final year however, this exposure is
also variable. If this clinical experience is coupled with an adjunct capacity building mode
using an online platform. there is a possibility that students could be trained in a better
way.
Status | Enrolling by invitation |
Enrollment | 600 |
Est. completion date | September 30, 2020 |
Est. primary completion date | August 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: Inclusion Criteria for medical students: - Final year medical students studying in institutions in Rawalpindi/Islamabad registered under the higher education commission - Medical students whose heads have provided permission to undertake the study with them - Medical students who have provided a written consent to be included in the study. Inclusion Criteria for pneumonia patients - Patients less than five years diagnosed with no pneumonia, pneumonia or severe pneumonia - Parents/Carers who provide consent for their under five children to be videotaped. Exclusion Criteria: Exclusion Criteria fro medical students - Medical students withdrawing/leaving the institute - Medical students who are not in final year Exclusion Criteria for pneumonia patients - Patients under five suffering from comorbidity with pneumonia |
Country | Name | City | State |
---|---|---|---|
Pakistan | MNCHRN | Islamabad | Federal |
Lead Sponsor | Collaborator |
---|---|
University of Edinburgh | Maternal, Neonatal and Child Health Research Network |
Pakistan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline knowledge of all participants on under five pneumonia at 6 months | Self administered questionnaire with multiple choice questions will be filled by the participants | 6 months | |
Primary | Change from baseline confidence in skills of all participants in diagnosing and managing under five pneumonia at 6 months | Self-administered Likert scale questionnaire will be filled by the participants | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04244474 -
Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
|
Phase 1/Phase 2 | |
Completed |
NCT05815264 -
Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above
|
Phase 1 | |
Recruiting |
NCT04589936 -
Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care
|
N/A | |
Completed |
NCT02905383 -
The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital
|
N/A | |
Terminated |
NCT03944551 -
Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa
|
N/A | |
Completed |
NCT06210737 -
A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months,7 Months-5 Years
|
Phase 4 | |
Terminated |
NCT04660084 -
Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Withdrawn |
NCT05702788 -
Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)
|
Phase 2 | |
Not yet recruiting |
NCT04171674 -
Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.
|
N/A | |
Active, not recruiting |
NCT03140163 -
Screening for Pneumonia: A Comparison of Ultra Low Dose Chest CT [ULD-CT] and Conventional Chest Radiography [CXR]
|
N/A | |
Completed |
NCT02864420 -
Hospitalization at Home: The Acute Care Home Hospital Program for Adults
|
N/A | |
Completed |
NCT02638649 -
Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
|
||
Recruiting |
NCT02515565 -
Physiotherapy in Patients Hospitalized Due to Pneumonia.
|
N/A | |
Completed |
NCT02105298 -
Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)
|
N/A | |
Completed |
NCT01416519 -
Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation
|
N/A | |
Completed |
NCT01399723 -
Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia
|
Phase 3 | |
Completed |
NCT01446926 -
Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants
|
Phase 1 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Terminated |
NCT02358642 -
Drug to Prevent Pneumonia in the Tube Fed
|
Phase 4 |